The Chain: Protein Engineering Podcast
The Chain explores the lives, careers, research, and discoveries of protein engineers and scientists, the impact their work is having on the field, and where the industry is headed. Tune in to stay up-to-date on the newest advancements and to hear the stories that are impacting the world of biologics.
- Update frequency
- every 20 days
- Average duration
- 29 minutes
- Episodes
- 80
- Years Active
- 2019 - 2025
Episode 17: Diagnostic Testing Approaches to the Coronavirus
In the fight against Coronavirus, there have been many calls for widespread testing. Dr. Nathan Ledeboer explains the power diagnostic testing has when combatting a pandemic, and the importance for c…
Episode 16: Suppressing the Spread of Coronavirus from a Public Health Perspective
The coronavirus has swept the globe, bringing governments, economies, and society to its knees. Infectious disease expert, Dr. Rita Rio discusses current suppression policies and long-term implicatio…
Episode 15: Cancer Immunotherapy Trends to Impact Patients and R&D
Today’s episode features a conversation with Dr. Tatiana Novobrantseva, Co-Founder and CSO of Verseau Therapeutics. In this interview, we discuss five trends in the development of cancer immunothera…
Episode 14: Science Commune: Biologists, Engineers, Artists, and Aha Moments w/ Bruce Keyt & Daniel Chen
Science Commune is a segment of The Chain that goes beyond the science and explores the people making discoveries. We discuss their career paths, passions, and the people who inspired them along the …
Episode 13: When Gene Editing Goes Too Far w/ Hank Greely
Hank Greely, JD is a leading expert in law, and particularly its applications in scientific advancement, and the ethical concerns brought about by gene editing, specifically. Recent events, including…
Episode 12: A Fireside Chat with Kathryn Hastie & Jamie Spangler - Part 2
Today’s episode continues the conversation with the 2019 and 2020 PEGS Young Scientist Keynote speakers, focusing on the challenges of their day to day work, the translation of major biotherapeutic a…
Episode 11: A Fireside Chat with Kathryn Hastie & Jamie Spangler - Part I
Today’s episode features a conversation with the 2019 and 2020 PEGS Young Scientist Keynote presenters. We explore their work in protein science, its impact on global health and some exciting initiat…
Episode 10: Intelligent Data Flow through Biotherapeutic Protein Development w/ Cenk Ündey, PhD
Some scientists dream of genes. Cenk Ündey dreams of intelligent data flow through the value-added chain of biotherapeutic protein development. Ündey is an Executive Director of Process Development a…
Episode 09: Engineered Multi-Specific Antibodies for Targeted Inhibition of Cancer Metastasis w/ Jamie Spangler
One of the greatest afflictions associated with cancer is its spread throughout the body and organs, known as metastasis. What if a therapeutic could be engineered to block the pathway of metastasis,…
Episode: 08 - Democratizing Cell-Free Protein Synthesis w/ Javin Oza, PhD
Javin Oza observed the separation of scientists and engineers on university campuses, at conferences, and in classrooms. Yet he also noted that advances in biochemistry require perspectives from both…
Episode: 07 - From Sequence to Product: Exploring Role of Aggregation and Developability in Biologics Product Development with Paolo Arosio, PhD
Dr. Paolo Arosio Professor of Biochemical Engineering at ETH Zurich speaks to Nandini Kashyap, Conference Director at CHI about his love for building blocks and how he is applying microfluidics to so…
Bonus Episode: Versatope and the Universal Influenza Vaccine with Christopher Locher, PhD
Versatope Therapeutics, Inc. was recently awarded up to $17.9 million by the NIH to develop a universal influenza vaccine. CEO and Co-Founder, Dr. Christopher Locher walks us through the early days o…
Bonus Episode: Research Technologies for Synthetic Immunology with Sai Reddy, PhD
Today’s episode explores the growing field of systems immunology, and how new informatics tools will be used in this discipline to discover and develop the next generation of biotherapeutics for canc…
Episode: 06 - Progress with Bispecific Vγ9Vδ2-T Cell Engagers w/ Dr. Paul Parren
Dr Parren speaks about advances in the field of T cell engaging bispecifics. Recent advances in bispecific antibody production and clinic successes have resulted in increased interest, but several d…
Episode 05: Hot Topics in Continuous Chromatography for Protein Purification w/ Dr. Massimo Morbidelli
Dr. Massimo Morbidelli is giving the Keynote Presentation in the “Protein Purification Technologies” conference that’s part of CHI’s 11th annual PEGS Summit Europe in Lisbon Portugal. Dr. Morbidelli…
Episode 04: Toward in silico Lead Discovery – the Advent of AI and Machine Learning w/ Lars Linden, PhD, Head, Protein Biochemistry, Biologics Research, Bayer
Dr. Lars Linden will be presenting during the Optimisation & Developability conference at PEGS Europe Summit, November 18-22, in Lisbon, Portugal. He speaks with CHI on August 6, 2019 to share his cu…
Episode 03: Science Stories and the Return of Cell-Free Synthesis with Dr. Marco Casteleijn
Over fifty years since its first use, Dr. Marco Casteleijn breaks down the resurgence of cell-free protein synthesis and its application across industries, including VTT’s research of cell-free prote…
Episode 02: Science Commune with Daniel Chen and Teemu Junttila
Science Commune is a segment of The Chain that goes beyond the science and explores the people making discoveries. We discuss their career paths, passions, and the people who inspired them along the …
Episode 01: International Collaboration Yields Therapeutic Protein with Genome Engineered CHO Cells. Bjørn Voldborg, Technical University
Bjørn Voldborg of the Technical University of Denmark speaks to CHI on July 18, 2019. He will be speaking during the Optimising Expression Platforms meeting at PEGS Europe, 18-22 November, in Lisbon,…
Episode 0: Welcome to The Chain
The Chain is a new podcast all about protein engineering and exploring the industry of biologics. We will learn from the experts what is new in the field and where it is heading. We will also be lear…